Women diagnosed with breast or gynecologic cancers underutilized both assisted reproductive technology and fertility-sparing oncology care, according to study results.
The findings, presented during the Society of Gynecologic Oncology 2022 Annual Meeting on Women’s Cancer, additionally showed that women residing in urban vs. rural areas and those with private insurance vs. Medicaid used assisted reproductive technology and fertility-sparing oncology care more frequently, regardless of cancer type.
Two beneficial approaches to preserve fertility are available for women diagnosed with